Target Price | $293.76 |
Price | $267.54 |
Potential | 9.80% |
Number of Estimates | 19 |
19 Analysts have issued a price target Travelers 2026 . The average Travelers target price is $293.76. This is 9.80% higher than the current stock price. The highest price target is $327.60 22.45% , the lowest is $227.36 15.02% . | |
A rating was issued by 28 analysts: 12 Analysts recommend Travelers to buy, 14 to hold and 2 to sell. | |
Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis. | |
Analyst Estimates: Analysts believe that the Travelers stock has an average upside potential 2026 of 9.80% . Most analysts recommend the Travelers stock at Hold. |
17 Analysts have issued a sales forecast Travelers 2025 . The average Travelers sales estimate is $46.2b . This is 1.82% lower than the revenue of the last 12 months(TTM). The highest sales forecast is $48.4b 3.04% , the lowest is $44.3b 5.70% .
This results in the following potential growth metrics:
2024 | $46.4b | 12.23% |
---|---|---|
2025 | $46.2b | 0.57% |
2026 | $48.9b | 5.96% |
2027 | $51.1b | 4.40% |
2028 | $51.1b | 0.00% |
2029 | $52.6b | 3.09% |
2 Analysts have issued an Travelers EBITDA forecast 2025. The average Travelers EBITDA estimate is $6.7b . This is 50.12% lower than the EBITDA of the last 12 months(TTM). The highest EBITDA forecast is $7.0b 48.14% , the lowest is $6.5b 51.60% .
This results in the following potential growth metrics and future EBITDA Margins:
2024 | $14.3b | 33.28% |
---|---|---|
2025 | $6.7b | 53.02% |
2026 | $8.6b | 28.10% |
2027 | $7.9b | 8.03% |
2024 | 30.74% | 18.75% |
---|---|---|
2025 | 14.52% | 52.76% |
2026 | 17.56% | 20.94% |
2027 | 15.47% | 11.90% |
25 Travelers Analysts have issued a net profit forecast 2025. The average Travelers net profit estimate is $4.3b . This is 2.26% higher than the net profit for the last 12 months(TTM). The highest net profit forecast is $4.9b 15.96% , the lowest is $3.7b 11.58% .
This results in the following potential growth metrics and future Net Margins:
2024 | $5.0b | 67.09% |
---|---|---|
2025 | $4.3b | 12.67% |
2026 | $5.6b | 29.97% |
2027 | $6.2b | 10.23% |
2028 | $4.7b | 23.97% |
2029 | $5.5b | 17.46% |
2024 | 10.69% | 48.88% |
---|---|---|
2025 | 9.39% | 12.13% |
2026 | 11.51% | 22.58% |
2027 | 12.16% | 5.65% |
2028 | 9.24% | 24.01% |
2029 | 10.53% | 13.96% |
25 Analysts have issued a Travelers forecast for earnings per share. The average Travelers EPS is $19.12 . This is 4.08% higher than earnings per share in the financial year 2024. The highest EPS forecast is $21.68 18.02% , the lowest is $16.53 10.02% .
This results in the following potential growth metrics and future valuations:
2024 | $21.47 | 67.87% |
---|---|---|
2025 | $19.12 | 10.95% |
2026 | $24.85 | 29.97% |
2027 | $27.39 | 10.22% |
2028 | $20.83 | 23.95% |
2029 | $24.46 | 17.43% |
Current | 14.33 | 8.31% |
---|---|---|
2025 | 13.77 | 3.93% |
2026 | 10.60 | 23.02% |
2027 | 9.61 | 9.34% |
2028 | 12.64 | 31.53% |
2029 | 10.76 | 14.87% |
Based on analysts' sales estimates for 2025, the Travelers stock is valued at an EV/Sales of 1.47 and an P/S ratio of 1.29 .
This results in the following potential growth metrics and future valuations:
Current | 1.44 | 9.92% |
---|---|---|
2025 | 1.47 | 1.84% |
2026 | 1.38 | 5.63% |
2027 | 1.33 | 4.22% |
2028 | 1.33 | 0.00% |
2029 | 1.29 | 3.00% |
Current | 1.27 | 13.29% |
---|---|---|
2025 | 1.29 | 1.85% |
2026 | 1.22 | 5.63% |
2027 | 1.17 | 4.21% |
2028 | 1.17 | 0.00% |
2029 | 1.13 | 3.00% |
Analyst | Rating | Action | Date |
---|---|---|---|
Keefe, Bruyette & Woods |
Outperform
➜
Outperform
|
Unchanged | May 28 2025 |
Morgan Stanley |
Equal-Weight
➜
Equal-Weight
|
Unchanged | May 19 2025 |
Evercore ISI Group |
Outperform
➜
Outperform
|
Unchanged | Apr 17 2025 |
Keefe, Bruyette & Woods |
Outperform
➜
Outperform
|
Unchanged | Apr 17 2025 |
Wells Fargo |
Equal-Weight
➜
Equal-Weight
|
Unchanged | Apr 17 2025 |
Jefferies |
Hold
➜
Hold
|
Unchanged | Apr 11 2025 |
Barclays |
Overweight
➜
Overweight
|
Unchanged | Apr 11 2025 |
Analyst Rating | Date |
---|---|
Unchanged
Keefe, Bruyette & Woods:
Outperform
➜
Outperform
|
May 28 2025 |
Unchanged
Morgan Stanley:
Equal-Weight
➜
Equal-Weight
|
May 19 2025 |
Unchanged
Evercore ISI Group:
Outperform
➜
Outperform
|
Apr 17 2025 |
Unchanged
Keefe, Bruyette & Woods:
Outperform
➜
Outperform
|
Apr 17 2025 |
Unchanged
Wells Fargo:
Equal-Weight
➜
Equal-Weight
|
Apr 17 2025 |
Unchanged
Jefferies:
Hold
➜
Hold
|
Apr 11 2025 |
Unchanged
Barclays:
Overweight
➜
Overweight
|
Apr 11 2025 |
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.